MagicMed Industries Announces Closing of Upsized and Oversubscribed $8.1 Million Private Placement of Units Led by Gravitas Securities Due to Significant Investor Demand Dec 18 • 4 min read MagicMed Industries Inc. announced the closing of its upsized and oversubscribed previously announced private placement of units of the company for aggregate gross proceeds of approximately $8.1M.
Tryp Therapeutics Completes Initial Public Offering Dec 17 • 3 min read Tryp Therapeutics Inc. announced the successful closing of its previously announced initial public offering.
Numinus Completes First Extraction of its Psilocybe Mushrooms Dec 17 • 5 min read Numinus Wellness Inc. has completed the first legal extraction of Psilocybe mushrooms in Canada by a public company for research and development purposes.
Ehave, Inc. Announces KetaDASH for Ketamine Home Delivery and Purchase of Curedash Assets Dec 16 • 4 min read Ehave, Inc. announced KetaDASH, an Intravenous (IV) based, home delivery platform for patients who have been prescribed Ketamine.
PharmaTher Files U.S. Patent for Novel Combinations of Psilocybin and FDA Approved Drugs to Treat Neurological Disorders Dec 15 • 3 min read PharmaTher Inc. announced that it has filed a provisional patent outlining the potential for novel combinations of psilocybin and U.S. Food and Drug Administration approved drugs to treat neurological disorders.